← INTEGRA LIFESCIENCES HOLDINGS CORP IART
Market Price
$18.34
Market Cap
$1.42B
P/E Ratio
N/A
Revenue (FY 2025)
↑1.5% YoY
$1.64B
3-Yr CAGR: 1.6%
Net Income
↓-7,337.7% YoY
-$516.47M
Net Margin: -31.6%
Free Cash Flow
↓-224.4% YoY
-$31.05M
FCF Yield: -2.19%
EPS (Diluted)
↓-7,388.9% YoY
$-6.74
Basic: $-6.74
Return on Equity
Efficiency
-49.5%
ROA: -44.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (IART)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $992.1M | — | $643.0M | $74.6M | — | $0.94 | — | $116.4M | $69.1M | — |
| FY 2017 | $1,188.2M | +19.8% | $752.7M | $64.7M | -13.2% | $0.82 | -12.8% | $114.5M | $71.0M | +2.8% |
| FY 2018 | $1,472.4M | +23.9% | $900.9M | $60.8M | -6.1% | $0.72 | -12.2% | $199.7M | $121.9M | +71.7% |
| FY 2019 | $1,517.6M | +3.1% | $952.9M | $50.2M | -17.4% | $0.58 | -19.4% | $231.4M | $161.9M | +32.8% |
| FY 2020 | $1,371.9M | -9.6% | $851.0M | $133.9M | +166.7% | $1.57 | +170.7% | $203.8M | $164.9M | +1.9% |
| FY 2021 | $1,542.4M | +12.4% | $944.6M | $169.1M | +26.3% | $1.98 | +26.1% | $312.4M | $264.4M | +60.3% |
| FY 2022 | $1,557.7M | +1.0% | $970.3M | $180.6M | +6.8% | $2.16 | +9.1% | $264.5M | $222.1M | -16.0% |
| FY 2023 | $1,541.6M | -1.0% | $884.7M | $67.7M | -62.5% | $0.84 | -61.1% | $140.0M | $73.1M | -67.1% |
| FY 2024 | $1,610.5M | +4.5% | $882.1M | $-6.9M | -110.3% | $-0.09 | -110.7% | $129.4M | $25.0M | -65.8% |
| FY 2025 | $1,635.2M | +1.5% | $831.6M | $-516.5M | -7,337.7% | $-6.74 | -7,388.9% | $50.4M | $-31.1M | -224.4% |
Valuation
Market Price
$18.34
Market Cap
$1.42B
Enterprise Value
$1.91B
P/E Ratio
N/A
P/B Ratio
1.37
FCF Yield
-2.19%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
50.86%
Operating Margin
-30.17%
Net Margin
-31.58%
Return on Equity (ROE)
-49.50%
Return on Assets (ROA)
-44.54%
Asset Turnover
1.41x
Revenue 3-Yr CAGR
1.63%
Financial Health & Liquidity
Current Ratio
8.89
Cash Ratio
1.80
Debt / Equity
0.696
Debt / Assets
0.627
Cash & Equivalents
$235.05M
Total Debt
$726.56M
Book Value / Share
$13.41
Cash Flow Efficiency
Operating Cash Flow
$50.38M
Capital Expenditures (CapEx)
$81.44M
Free Cash Flow
-$31.05M
OCF / Revenue
3.08%
FCF / Revenue
-1.90%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-6.74
EPS (Basic)
$-6.74
Dividends / Share
N/A
Book Value / Share
$13.41
EPS YoY Growth
-7,388.89%
Balance Sheet (FY 2025)
Total Assets
$1.16B
Total Liabilities
$130.49M
Stockholders' Equity
$1.04B
Current Assets
$1.16B
Current Liabilities
$130.49M